Anti-CGRP monoclonal antibody exposure was associated with increased risk of spontaneous abortion vs unexposed individuals ...

CGRP antagonists are a new class of drugs designed to prevent migraine headaches by targeting a key molecule involved in pain transmission. Calcitonin gene-related peptide (CGRP) monoclonal antibodies ...

I know there are injections. But aren't they expensive?”This is a common response in the exam room when I talk about prevention. Sometimes people feel awkward asking about the price, and the topic ...

A common migraine drug has been linked to an alarming health risk.

Washington, DC — New phase 2 data on the investigational calcitonin gene-related peptide (CGRP) monoclonal antibodies show significant efficacy in preventing migraine attacks with no major safety ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

"When headaches persist, my mood sinks and feels gloomy...""I feel restless every day, anxious about when the pain might ...

In its first update since 2012, the American Academy of Neurology's new migraine treatment guidelines mean more people can get help.

As its oral CGRP rimegepant moves closer to an FDA decision, Biohaven Pharma has become a target for M&A talks. (Biohaven Pharma) Aiming to break into a three-way battle among large drugmakers in the ...

Teva Pharmaceutical Industries Ltd. TEVA announced that its anti-calcitonin gene-related peptide (“CGRP”) injection, Ajovy, was granted marketing approval by the European Commission for prophylaxis of ...